- ¹⁸F-FDG and ¹⁸F-FLT uptake profiles for breast cancer cell lines treated with targeted PI3K/Akt/mTOR therapies(2023)
Authors: Yanina Dockx, Christel Vangestel, Sven De Bruycker, Tim Van den Wyngaert, Manon Huizing, Steven Staelens, Sigrid Stroobants
Pages: 51 - 61
- ATG4B inhibitor UAMC-2526 potentiates the chemotherapeutic effect of gemcitabine in a Panc02 mouse model of pancreatic ductal adenocarcinoma(2021)
Authors: Sedigheh Takhsha, Christel Vangestel, Muhammet Tanc, Sven De Bruycker, Maya Berg, Isabel Pintelon, Sigrid Stroobants, Guido De Meyer, Pieter Van Der Veken, Wim Martinet
- Early changes in [¹⁸F]FDG uptake as a readout for PI3K/Akt/mTOR targeted drugs in HER-2-positive cancer xenografts(2021)
Authors: Yanina Dockx, Christel Vangestel, Tim Van den Wyngaert, Manon Huizing, Sven De Bruycker, Patrick Pauwels, Steven Staelens, Sigrid Stroobants
- Targeting fibroblast activation protein (FAP)(2020)
Authors: Euy Sung Moon, Gwendolyn Vliegen, Christel Vangestel, Sven De Bruycker, An Bracke, Elisabeth Eppard, Lukas Greifenstein, Benedikt Klasen, Vasko Kramer, Steven Staelens, et al.
- $^{18}F$-HX4 hypoxia PET holds promise as a prognostic and predictive imaging biomarker in a lung cancer xenograft model treated with metformin and radiotherapy(2019)
Authors: Sven De Bruycker, Christel Vangestel, Tim Van den Wyngaert, Patrick Pauwels, Leonie Wyffels, Steven Staelens, Sigrid Stroobants
Pages: 34 - 40
- Effects of metformin on tumor hypoxia and radiotherapy efficacy: a$[^{18}F]$HX4 PET imaging study in colorectal cancer xenografts(2019)
Authors: Sven De Bruycker, Christel Vangestel, Steven Staelens, Leonie Wyffels, Jan Detrez, Marlies Verschuuren, Winnok De Vos, Patrick Pauwels, Tim Van den Wyngaert, Sigrid Stroobants
- Radiosensitization of non-small cell lung cancer cells by the Plk1 inhibitor volasertib is dependent on the p53 status(2019)
Authors: Andreas Domen, Marc Peeters, Ines De Pauw, Julie Jacobs, Sven De Bruycker, Pol Specenier, Patrick Pauwels, Jan Vermorken, An Wouters
- Imaging biomarkers for the modulation of the hypoxic tumor microenvironment(2019)
Authors: Sven De Bruycker, Sigrid Stroobants, Christel Vangestel
Number of pages: 180
- How to modulate tumor hypoxia for preclinical in vivo imaging research(2018)
Authors: Sven De Bruycker, Christel Vangestel, Steven Staelens, Tim Van den Wyngaert, Sigrid Stroobants
- Baseline $[^{18}F]FMISO$ $\mu PET$ as a predictive biomarker for response to $HIF-1\alpha$ inhibition combined with 5-FU chemotherapy in a human colorectal cancer xenograft model(2016)
Authors: Sven De Bruycker, Christel Vangestel, Tim Van den Wyngaert, Leonie Wyffels, An Wouters, Patrick Pauwels, Steven Staelens, Sigrid Stroobants
Pages: 606 - 616